Metropolitan Life Insurance CO Fulcrum Therapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$2.83 - $13.99 $2,181 - $10,786	771 Added 37.1%	2,849 $8,000
Q4 2022 Jun 14, 2023	SELL	$5.01 - $8.35 $3,862 - $6,437	-771 Reduced 27.06%	2,078 $15.1 Million
Q3 2022 Jun 14, 2023	SELL	$4.92 - $9.1 $3,793 - $7,016	-771 Reduced 27.06%	2,078 $16.8 Million
Q3 2022 Mar 30, 2023	BUY	$4.92 - $9.1 $1,451 - $2,684	295 Added 16.55%	2,078 $16,000
Q3 2022 Nov 14, 2022	BUY	$4.92 - $9.1 $10,223 - $18,909	2,078 New	2,078 $17,000
Q2 2022 Aug 11, 2022	SELL	$4.2 - $24.0 $7,488 - $42,792	-1,783 Closed	0 $0
Q1 2022 Jun 20, 2023	SELL	$9.96 - $23.65 $10,617 - $25,210	-1,066 Reduced 37.42%	1,783 $42,000
Q1 2022 Mar 30, 2023	SELL	$9.96 - $23.65 $54,242 - $128,797	-5,446 Reduced 75.34%	1,783 $42,000
Q1 2022 May 12, 2022	SELL	$9.96 - $23.65 $54,242 - $128,797	-5,446 Reduced 75.34%	1,783 $42,000
Q4 2021 Jun 21, 2023	BUY	$14.0 - $28.44 $61,320 - $124,567	4,380 Added 153.74%	7,229 $127,000
Q3 2021 Jun 21, 2023	BUY	$7.28 - $30.97 $31,886 - $135,648	4,380 Added 153.74%	7,229 $203,000
Q3 2021 Mar 30, 2023	BUY	$7.28 - $30.97 $21,119 - $89,843	2,901 Added 67.03%	7,229 $203,000
Q3 2021 Nov 15, 2021	BUY	$7.28 - $30.97 $52,627 - $223,882	7,229 New	7,229 $204,000
Q3 2020 Nov 13, 2020	SELL	$7.22 - $20.7 $31,248 - $89,589	-4,328 Closed	0 $0
Q2 2020 Jun 26, 2023	BUY	$9.11 - $22.06 $13,473 - $32,626	1,479 Added 51.91%	4,328 $79,000
Q2 2020 Mar 30, 2023	BUY	$9.11 - $22.06 $20,497 - $49,635	2,250 Added 108.28%	4,328 $79,000
Q2 2020 Aug 14, 2020	BUY	$9.11 - $22.06 $39,428 - $95,475	4,328 New	4,328 $79,000
Q1 2020 Jul 12, 2023	SELL	$9.49 - $21.26 $17,404 - $38,990	-1,834 Reduced 64.37%	1,015 $12.1 Million

Others Institutions Holding FULC

# of Institutions

150

Shares Held

52.2M

Call Options Held

6.91M

Put Options Held

1.9M

Ra Capital Management, L.P. Boston, MA

10.2M
Shares

$46.5 Million
0.51% of portfolio
Tcg Crossover Management, LLC Palo Alto, CA

5.25M
Shares

$23.9 Million
2.43% of portfolio
Black Rock Inc. New York, NY

4.8M
Shares

$21.8 Million
0.0% of portfolio
Nantahala Capital Management, LLC New Canaan, CT

4.78M
Shares

$21.7 Million
1.01% of portfolio
Vanguard Group Inc Valley Forge, PA

3.27M
Shares

$14.9 Million
0.0% of portfolio

View Full List

About Fulcrum Therapeutics, Inc.

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $237M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

More about FULC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account